Aion Therapeutic Inc. (ANTCF)

Aion Therapeutic Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 13, 2026	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Market Capitalization	2	6	1	2	9	1
Market Cap Growth	-60.80%	451.36%	-50.91%	-75.73%	763.01%	-76.61%
Enterprise Value	4	7	2	3	9	1
Last Close Price	0.00	0.01	0.00	0.01	0.08	-
PS Ratio	1.77	22.40	-	-	-	-
PB Ratio	-0.56	-2.13	-0.54	-1.18	28.26	0.69
P/TBV Ratio	-	-	-	-	28.26	0.69
EV/Sales Ratio	3.59	26.99	-	-	-	-
Debt / Equity Ratio	-0.60	-0.54	-0.36	-0.31	1.43	0.45
Net Debt / Equity Ratio	-0.60	-0.52	-0.36	-0.31	0.82	0.16
Net Debt / EBITDA Ratio	-1.87	-1.79	-1.15	-0.32	-0.13	-0.41
Net Debt / FCF Ratio	-1.81	-2.38	-23.43	-0.55	-0.15	-0.46
Asset Turnover	0.42	0.81	-	-	-	-
Quick Ratio	0.03	0.03	0.07	0.06	0.20	1.43
Current Ratio	0.19	0.12	0.07	0.06	0.39	1.56
Return on Equity (ROE)	-	-	-	-	-652.93%	-28.20%
Return on Assets (ROA)	-26.86%	-156.04%	-297.81%	-170.42%	-65.85%	-16.16%
Return on Capital Employed (ROCE)	32.60%	29.50%	31.50%	99.30%	-654.70%	-33.70%
Earnings Yield	-255.51%	-76.38%	-17.42%	-134.64%	-73.58%	-45.86%
FCF Yield	-	-10.27%	-2.81%	-47.49%	-18.99%	-51.55%
Buyback Yield / Dilution	-129.87%	-81.07%	-4.65%	-48.98%	-161.64%	-30.62%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.